Eterna Therapeutics Inc (NASDAQ:ERNA) currently has a daily average trading volume of 11.07M but it saw 1161255 shares traded in last market. With a market cap of 18.82M USD, the company’s current market price of $0.37 came falling about -14.79 while comparing to the previous closing price of $0.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.62 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.36 while lowest mark touched by it was $0.44.
Taking a look at 20-day trading activity of Eterna Therapeutics Inc (ERNA) gives us an average price of $0.4147, while its current price level is -86.04% below from 52-week high level whereas it is 65.64% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3999 while that of 200 days or SMA-200 reads an average of $1.3370. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.32% during that period while stretching the period over a month that increases to 26.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 44.43 which implies that the stock is in neutral territory.
Over the week, ERNA’s stock price is moving -36.83% down while it is 44.82% when we observe its performance for the past one month. Year-to-date it is 24.63% up and over the past year, the stock is showing a downside performance of -78.06%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Eterna Therapeutics Inc’s total number of outstanding shares is 51.37M with 336.35% of that held by the insiders while 11.00% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1154.18%. Stock’s beta reads 4.35. Stock has a price to sale or P/S ratio amounts to 31.37. Its return on asset (ROA) is -149.86% on average.
